Canaccord Genuity Group Raises 5N Plus (TSE:VNP) Price Target to C$34.00

5N Plus (TSE:VNP) had its price objective increased by stock analysts at Canaccord Genuity Group from C$31.00 to C$34.00 in a research report issued to clients and investors on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would indicate a potential upside of 14.63% from the company’s previous close.

A number of other research analysts have also recently commented on the stock. Ventum Financial upped their target price on shares of 5N Plus from C$30.00 to C$35.00 and gave the company a “buy” rating in a research report on Thursday. ATB Cormark Capital Markets decreased their price objective on shares of 5N Plus from C$42.00 to C$37.50 and set a “top pick” rating on the stock in a report on Tuesday, February 3rd. National Bank Financial lifted their target price on shares of 5N Plus from C$30.00 to C$33.00 and gave the company an “outperform” rating in a report on Wednesday, February 4th. Raymond James Financial raised their price target on 5N Plus from C$24.00 to C$26.00 in a research report on Wednesday, November 5th. Finally, Desjardins boosted their price objective on 5N Plus from C$24.50 to C$30.00 and gave the company a “buy” rating in a report on Monday, February 2nd. Two investment analysts have rated the stock with a Strong Buy rating and five have issued a Buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of C$34.08.

5N Plus Trading Down 2.6%

VNP opened at C$29.66 on Thursday. The stock has a market capitalization of C$2.64 billion, a PE ratio of 60.53, a P/E/G ratio of 6,283.33 and a beta of 1.19. 5N Plus has a one year low of C$4.90 and a one year high of C$31.35. The company has a debt-to-equity ratio of 104.29, a quick ratio of 1.51 and a current ratio of 3.49. The business’s 50 day moving average price is C$22.75 and its 200 day moving average price is C$19.39.

5N Plus (TSE:VNP) last posted its earnings results on Tuesday, February 24th. The company reported C$0.10 EPS for the quarter. The company had revenue of C$134.21 million for the quarter. 5N Plus had a return on equity of 11.86% and a net margin of 5.63%. As a group, equities research analysts expect that 5N Plus will post 0.3739703 EPS for the current year.

More 5N Plus News

Here are the key news stories impacting 5N Plus this week:

• Positive Sentiment: Raymond James raised its price target on 5N Plus to C$35.00 (from C$29.00) and assigned an “outperform” rating, implying roughly a 15% upside vs the cited reference price. Article Title
• Positive Sentiment: Ventum Financial increased its target to C$35.00 (from C$30.00) and kept a “buy” rating — another analyst note implying ~15% upside. Article Title
• Positive Sentiment: Canaccord Genuity raised its target to C$34.00 (from C$31.00) and reaffirmed a “buy” rating, suggesting ~11.7% upside. Article Title
• Neutral Sentiment: Multiple outlets (BayStreet.ca, TickerReport) have carried these analyst updates, confirming wider coverage of the upgrades; the notes focus on upside from current levels rather than material changes to fundamentals. BayStreet Coverage TickerReport
• Neutral Sentiment: Context that may explain muted/negative intraday reaction: VNP carries a high trailing P/E (~60.5) and elevated debt-to-equity (~104%), and it recently reached a 12‑month high — factors that can prompt profit‑taking or cautious positioning despite upgrades.

About 5N Plus

5N+ is a leading global producer of specialty semiconductors and performance materials. The Company’s ultra pure materials often form the core element of its customers’ products. These customers rely on 5N+’s products to enable performance and sustainability in their own products. 5N+ deploys a range of proprietary and proven technologies to develop and manufacture its products. The Company’s products enable various applications in several key industries, including renewable energy, security, space, pharmaceutical, medical imaging and industrial.